The Case Control or Retrospective Study In Retrospect
- 1 July 1981
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (7) , 269-274
- https://doi.org/10.1002/j.1552-4604.1981.tb01765.x
Abstract
The epidemiologic case control design is described against background information on its resurgence in popularity despite historical criticisms posed by its detractors. Weaknesses charged to the design by Feinstein and others such as its potential for recall bias in the use of retrospective data, Neyman's case selection bias, and the diagnostic suspicion bias are analyzed and shown to affect both the cohort incidence design and the clinical trial design as well as the case control.Keywords
This publication has 11 references indexed in Scilit:
- Bias in analytic researchPublished by Elsevier ,2004
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- The evolving case-control studyJournal of Chronic Diseases, 1979
- CommentJournal of Chronic Diseases, 1979
- Retrospective StudiesAnnals of Internal Medicine, 1974
- Clinical biostatistics; xx. The epidemiologic trohoc, the ablative risk ratio, and ‘retrospective’ researchClinical Pharmacology & Therapeutics, 1973
- Adenocarcinoma of the VaginaNew England Journal of Medicine, 1971
- Investigation of relation between use of oral contraceptives and thromboembolic disease.BMJ, 1968
- Prospective versus retrospective approach in the search for environmental causes of malformations.American Journal of Public Health and the Nations Health, 1967
- Statistics—Servant of All ScienceScience, 1955